Wendy F Dicicco - Net Worth and Insider Trading

Wendy F Dicicco Net Worth

The estimated net worth of Wendy F Dicicco is at least $2 Million dollars as of 2024-04-26. Wendy F Dicicco is the Director of Coherent Corp and owns about 30,546 shares of Coherent Corp (COHR) stock worth over $2 Million. Details can be seen in Wendy F Dicicco's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wendy F Dicicco has not made any transactions after 2017-04-28 and currently still holds the listed stock(s).

Transaction Summary of Wendy F Dicicco

Wendy F Dicicco Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wendy F Dicicco owns 6 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , Coherent Corp (COHR) , and Cannapharmarx Inc (CPMD) among others .

Click here to see the complete history of Wendy F Dicicco’s form 4 insider trades.

Insider Ownership Summary of Wendy F Dicicco

Ticker	Comapny	Transaction Date	Type of Owner
EYPT	EyePoint Pharmaceuticals Inc	2019-07-15	director
COHR	Coherent Corp	2017-04-28	director
CPMD	Cannapharmarx Inc	2015-02-27	director
SWKH	SWK Holdings Corp	2022-02-15	director
RCOR	Renovacor Inc	2021-09-02	Interim CFO
CHAQ.U	Chardan Healthcare Acquisition 2 Corp	2021-09-02	Interim CFO

Wendy F Dicicco Latest Holdings Summary

Wendy F Dicicco currently owns a total of 1 stock. Wendy F Dicicco owns 30,546 shares of Coherent Corp (COHR) as of April 28, 2017, with a value of $2 Million.

Latest Holdings of Wendy F Dicicco

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
COHR	Coherent Corp	2017-04-28	30,546	52.88	1,615,272

Holding Weightings of Wendy F Dicicco

Wendy F Dicicco Form 4 Trading Tracker

According to the SEC Form 4 filings, Wendy F Dicicco has made a total of 0 transactions in Coherent Corp (COHR) over the past 5 years. The most-recent trade in Coherent Corp is the sale of 2,500 shares on April 28, 2017, which brought Wendy F Dicicco around $82,975.

Insider Trading History of Wendy F Dicicco

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wendy F Dicicco Trading Performance

GuruFocus tracks the stock performance after each of Wendy F Dicicco's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wendy F Dicicco is -4.45%. GuruFocus also compares Wendy F Dicicco's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wendy F Dicicco within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wendy F Dicicco's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wendy F Dicicco

Average Return

30.38%

Average return per transaction

Outperforming Transactions

75%

3 out of 4 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	2.55	-4.45	22.72	30.38	15.58	13.86
Relative Return to S&P 500(%)	0.76	1.64	19.83	32.69	19.02	11.45

Wendy F Dicicco Ownership Network

Ownership Network List of Wendy F Dicicco

No Data

Ownership Network Relation of Wendy F Dicicco

Wendy F Dicicco Owned Company Details

What does EyePoint Pharmaceuticals Inc do?

Who are the key executives at EyePoint Pharmaceuticals Inc?

Wendy F Dicicco is the director of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include SVP & Chief Commercial Officer David Scott Jones , Chief Medical Officer Dario A. Paggiarino , and director & President and CEO Nancy Lurker .

EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary

Over the past 18 months, Wendy F Dicicco made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 3,944,057 shares made by Cormorant Asset Management, Lp .

In summary, during the past 3 months, insiders sold 209 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 581,765 shares, with a net purchase of 581,556 shares. During the past 18 months, 4,194,936 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 3,944,057 shares were bought by its insiders, resulting in a net sale of 250,879 shares.

EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

EyePoint Pharmaceuticals Inc Insider Transactions

No Available Data

What does Coherent Corp do?

Who are the key executives at Coherent Corp?

Wendy F Dicicco is the director of Coherent Corp. Other key executives at Coherent Corp include Vice President Mattera Vincent D Jr , General Counsel Bashaw Walter Robert Ii , and Chief Innovation Officer Christopher Koeppen .

Coherent Corp (COHR) Insider Trades Summary

Over the past 18 months, Wendy F Dicicco made no insider transaction in Coherent Corp (COHR). Other recent insider transactions involving Coherent Corp (COHR) include a net sale of 16,973 shares made by Christopher Koeppen , a net sale of 12,000 shares made by Mary Jane Raymond , and a net sale of 71,000 shares made by Mattera Vincent D Jr .

In summary, during the past 3 months, insiders sold 22,035 shares of Coherent Corp (COHR) in total and bought 0 shares, with a net sale of 22,035 shares. During the past 18 months, 158,402 shares of Coherent Corp (COHR) were sold and 6,041 shares were bought by its insiders, resulting in a net sale of 152,361 shares.

Coherent Corp (COHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Coherent Corp Insider Transactions

No Available Data

What does Cannapharmarx Inc do?

Who are the key executives at Cannapharmarx Inc?

Wendy F Dicicco is the director of Cannapharmarx Inc. Other key executives at Cannapharmarx Inc include director & Chief Executive Officer Dominic Colvin , Chief Financial Officer John Hamilton Cassels , and Chief Operating Officer Andrew Clifford Steedman .

Cannapharmarx Inc (CPMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cannapharmarx Inc (CPMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cannapharmarx Inc (CPMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cannapharmarx Inc (CPMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cannapharmarx Inc Insider Transactions

No Available Data

What does SWK Holdings Corp do?

Who are the key executives at SWK Holdings Corp?

Wendy F Dicicco is the director of SWK Holdings Corp. Other key executives at SWK Holdings Corp include Chief Financial Officer Yvette M Heinrichson , PRESIDENT Staggs Joe David Jr , and Chief Executive Officer Black Winston L Iii .

SWK Holdings Corp (SWKH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SWK Holdings Corp (SWKH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SWK Holdings Corp (SWKH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SWK Holdings Corp (SWKH)'s detailed insider trading history can be found in Insider Trading Tracker table.

SWK Holdings Corp Insider Transactions

No Available Data

What does Renovacor Inc do?

Who are the key executives at Renovacor Inc?

Wendy F Dicicco is the Interim CFO of Renovacor Inc. Other key executives at Renovacor Inc include Chief Accounting Officer Joseph S Carroll , Chief Financial Officer Frederick W Driscoll , and director & Chief Executive Officer Magdalene Cook .

Renovacor Inc (RCOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Renovacor Inc (RCOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Renovacor Inc (RCOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Renovacor Inc (RCOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Renovacor Inc Insider Transactions

No Available Data

What does Chardan Healthcare Acquisition 2 Corp do?

Who are the key executives at Chardan Healthcare Acquisition 2 Corp?

Wendy F Dicicco is the Interim CFO of Chardan Healthcare Acquisition 2 Corp. Other key executives at Chardan Healthcare Acquisition 2 Corp include Chief Accounting Officer Joseph S Carroll , Chief Financial Officer Frederick W Driscoll , and director & Chief Executive Officer Magdalene Cook .

Chardan Healthcare Acquisition 2 Corp (CHAQ.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chardan Healthcare Acquisition 2 Corp (CHAQ.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chardan Healthcare Acquisition 2 Corp Insider Transactions

No Available Data

Wendy F Dicicco Mailing Address

Above is the net worth, insider trading, and ownership report for Wendy F Dicicco. Currently GuruFocus does not have mailing address information for Wendy F Dicicco.

Discussions on Wendy F Dicicco

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.